Under the theme "Uncovering the Broad Spectrum of Psoriatic Disease," this year's conference aimed to foster international collaboration on research, advocacy initiatives, and awareness among medical professionals and industry stakeholders.
Delegates from over 76 countries convened at the IFPA Conference 2024, representing a diverse array of clinical experts, health professionals, and patient organizations. Accredited by the European Accreditation Council for Continuing Medical Education (EACCME), the conference featured over 190 abstracts covering pivotal topics such as biomarkers, imaging, and comorbidities.
A highlight of the conference was the recognition of exceptional e-posters through the Poster Prize. The event also showcased over 50 high-level presentations, spotlighting cutting-edge research and advancements in the field of psoriatic disease.
Professor April Armstrong, Conference President, remarked on the conference's impact: "We shared knowledge, engaged in meaningful conversations, and highlighted significant achievements in the prevention, diagnosis, and treatment of psoriatic disease. The IFPA conference serves as a platform to focus on future research and advance care for all persons living with psoriatic disease."
Ingvar